Moreover, ROC curve analysis was performed, revealing significant diagnostic potential for several biomarkers: Jun (P < 0.001, AUC = 0.892, 95% CI [0.775, 1.000]), NFKBIA (P = 0.003, AUC = 0.843, 95% CI [0.704, 0.981]), Fosl1 (P = 0.025, AUC = 0.755, 95% CI [0.583, 0.927]), CXCL2 (P = 0.028, AUC = 0.75, 95% CI [0.569, 0.931]), and CXCL8 (P = 0.002, AUC = 0.85, 95% CI [0.685, 1.000]), indicating their effectiveness in distinguishing between BD patients and healthy controls (Figure 6H). This evidence concerns the gene CXCL2 and Behcet disease.